{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T21:07:30Z","timestamp":1761426450957,"version":"build-2065373602"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Holliday Discovery Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-20602-9","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T09:27:42Z","timestamp":1761038862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive analysis of microRNA expression provides mechanistic insights into transcriptomic alteration in primary and metastatic testicular germ cell tumors"],"prefix":"10.1038","volume":"15","author":[{"given":"Taibo","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anirudh","family":"Yerrapragada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Br\u00f6nimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Rivera","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Cheaib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasser","family":"Ged","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezra","family":"Baraban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shawn E.","family":"Lupold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirmish","family":"Singla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,21]]},"reference":[{"key":"20602_CR1","first-page":"10","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel, R. L., Kratzer, T. B., Giaquinto, A. N., Sung, H. & Jemal, A. Cancer statistics, 2025. CA Cancer J. Clin. 75, 10\u201345 (2025).","journal-title":"CA Cancer J. Clin."},{"key":"20602_CR2","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00345-014-1361-y","volume":"33","author":"M Nigam","year":"2015","unstructured":"Nigam, M., Aschebrook-Kilfoy, B., Shikanov, S. & Eggener, S. Increasing incidence of testicular cancer in the United States and Europe between 1992 and 2009. World J. Urol. 33, 623\u2013631 (2015).","journal-title":"World J. Urol."},{"key":"20602_CR3","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: Target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"20602_CR4","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1158\/2159-8290.CD-15-0893","volume":"6","author":"R Rupaimoole","year":"2016","unstructured":"Rupaimoole, R., Calin, G. A., Lopez-Berestein, G. & Sood, A. K. miRNA deregulation in cancer cells and the tumor microenvironment. Cancer Discov. 6, 235\u2013246 (2016).","journal-title":"Cancer Discov."},{"key":"20602_CR5","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.juro.2014.07.010","volume":"193","author":"I Syring","year":"2015","unstructured":"Syring, I. et al. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. J. Urol. 193, 331\u2013337 (2015).","journal-title":"J. Urol."},{"key":"20602_CR6","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1200\/JCO.18.01480","volume":"37","author":"K-P Dieckmann","year":"2019","unstructured":"Dieckmann, K.-P. et al. Serum levels of MicroRNA-371a-3p (M371 Test) as a new biomarker of testicular germ cell tumors: Results of a prospective multicentric study. J. Clin. Oncol. 37, 1412\u20131423 (2019).","journal-title":"J. Clin. Oncol."},{"key":"20602_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.euros.2021.02.003","volume":"26","author":"JT Lafin","year":"2021","unstructured":"Lafin, J. T. et al. Serum small RNA sequencing and miR-375 assay do not identify the presence of pure teratoma at postchemotherapy retroperitoneal lymph node dissection. Eur. Urol. Open Sci. 26, 83\u201387 (2021).","journal-title":"Eur. Urol. Open Sci."},{"key":"20602_CR8","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41585-020-0296-x","volume":"17","author":"K Almstrup","year":"2020","unstructured":"Almstrup, K. et al. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours. Nat. Rev. Urol. 17, 201\u2013213 (2020).","journal-title":"Nat. Rev. Urol."},{"key":"20602_CR9","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","volume":"120","author":"SM Johnson","year":"2005","unstructured":"Johnson, S. M. et al. RAS is regulated by the let-7 microRNA family. Cell 120, 635\u2013647 (2005).","journal-title":"Cell"},{"key":"20602_CR10","doi-asserted-by":"publisher","first-page":"7165","DOI":"10.1158\/0008-5472.CAN-09-1448","volume":"69","author":"J Ribas","year":"2009","unstructured":"Ribas, J. et al. miR-21: An androgen receptor-regulated microRNA that promotes hormone-dependent and hormone-independent prostate cancer growth. Cancer Res. 69, 7165\u20137169 (2009).","journal-title":"Cancer Res."},{"key":"20602_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.4161\/cc.9.5.10930","volume":"9","author":"J Ribas","year":"2010","unstructured":"Ribas, J. & Lupold, S. E. The transcriptional regulation of miR-21, its multiple transcripts, and their implication in prostate cancer. Cell Cycle 9, 923\u2013929 (2010).","journal-title":"Cell Cycle"},{"key":"20602_CR12","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.1038\/s41598-018-25320-z","volume":"8","author":"B Kumar","year":"2018","unstructured":"Kumar, B. et al. Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer. Sci. Rep. 8, 7189 (2018).","journal-title":"Sci. Rep."},{"key":"20602_CR13","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1158\/1541-7786.MCR-18-0837","volume":"17","author":"K Zennami","year":"2019","unstructured":"Zennami, K. et al. PDCD4 is an androgen-repressed tumor suppressor that regulates prostate cancer growth and castration resistance. Mol. Cancer Res. 17, 618\u2013627 (2019).","journal-title":"Mol. Cancer Res."},{"key":"20602_CR14","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","volume":"23","author":"H Shen","year":"2018","unstructured":"Shen, H. et al. Integrated molecular characterization of testicular germ cell tumors. Cell Rep. 23, 3392\u20133406 (2018).","journal-title":"Cell Rep."},{"key":"20602_CR15","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/sj.bjc.6602560","volume":"92","author":"K Almstrup","year":"2005","unstructured":"Almstrup, K. et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. Br. J. Cancer 92, 1934\u20131941 (2005).","journal-title":"Br. J. Cancer"},{"key":"20602_CR16","doi-asserted-by":"publisher","first-page":"11898","DOI":"10.1093\/nar\/gky1066","volume":"46","author":"S Sakaue","year":"2018","unstructured":"Sakaue, S. et al. Integration of genetics and miRNA-target gene network identified disease biology implicated in tissue specificity. Nucleic Acids Res. 46, 11898\u201311909 (2018).","journal-title":"Nucleic Acids Res."},{"key":"20602_CR17","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrm3507","volume":"14","author":"A Eijkelenboom","year":"2013","unstructured":"Eijkelenboom, A. & Burgering, B. M. T. FOXOs: Signalling integrators for homeostasis maintenance. Nat. Rev. Mol. Cell Biol. 14, 83\u201397 (2013).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"20602_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0092-8674(04)00452-0","volume":"117","author":"D Accili","year":"2004","unstructured":"Accili, D. & Arden, K. C. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117, 421\u2013426 (2004).","journal-title":"Cell"},{"key":"20602_CR19","doi-asserted-by":"publisher","first-page":"8825","DOI":"10.1007\/s13277-015-4710-6","volume":"37","author":"G Browne","year":"2016","unstructured":"Browne, G. et al. MicroRNA-378-mediated suppression of Runx1 alleviates the aggressive phenotype of triple-negative MDA-MB-231 human breast cancer cells. Tumour Biol. 37, 8825\u20138839 (2016).","journal-title":"Tumour Biol."},{"key":"20602_CR20","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1159\/000369664","volume":"34","author":"T Ge","year":"2014","unstructured":"Ge, T., Yin, M., Yang, M., Liu, T. & Lou, G. MicroRNA-302b suppresses human epithelial ovarian cancer cell growth by targeting RUNX1. Cell Physiol. Biochem. 34, 2209\u20132220 (2014).","journal-title":"Cell Physiol. Biochem."},{"key":"20602_CR21","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.18632\/oncotarget.6736","volume":"7","author":"N Li","year":"2016","unstructured":"Li, N. et al. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1. Oncotarget 7, 4817\u20134828 (2016).","journal-title":"Oncotarget"},{"key":"20602_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.bbrc.2013.12.126","volume":"448","author":"M Zhuang","year":"2014","unstructured":"Zhuang, M., Gao, W., Xu, J., Wang, P. & Shu, Y. The long non-coding RNA H19-derived miR-675 modulates human gastric cancer cell proliferation by targeting tumor suppressor RUNX1. Biochem. Biophys. Res. Commun. 448, 315\u2013322 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"20602_CR23","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1073\/pnas.0811466106","volume":"106","author":"O Ben-Ami","year":"2009","unstructured":"Ben-Ami, O., Pencovich, N., Lotem, J., Levanon, D. & Groner, Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc. Natl. Acad. Sci. U. S. A. 106, 238\u2013243 (2009).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"20602_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/ncb1613","volume":"9","author":"L Fontana","year":"2007","unstructured":"Fontana, L. et al. MicroRNAs 17\u20135p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat. Cell Biol. 9, 775\u2013787 (2007).","journal-title":"Nat. Cell Biol."},{"key":"20602_CR25","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/jcp.25258","volume":"231","author":"MA Medina","year":"2016","unstructured":"Medina, M. A. et al. Alternative RUNX1 promoter regulation by Wnt\/\u03b2-catenin signaling in leukemia cells and human hematopoietic progenitors. J. Cell Physiol. 231, 1460\u20131467 (2016).","journal-title":"J. Cell Physiol."},{"key":"20602_CR26","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1101\/gad.1337005","volume":"19","author":"CE Burns","year":"2005","unstructured":"Burns, C. E., Traver, D., Mayhall, E., Shepard, J. L. & Zon, L. I. Hematopoietic stem cell fate is established by the Notch-Runx pathway. Genes Dev. 19, 2331\u20132342 (2005).","journal-title":"Genes Dev."},{"key":"20602_CR27","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/ije\/dyq260","volume":"40","author":"MB Cook","year":"2011","unstructured":"Cook, M. B. et al. Genetic contributions to the association between adult height and testicular germ cell tumors. Int. J. Epidemiol. 40, 731\u2013739 (2011).","journal-title":"Int. J. Epidemiol."},{"key":"20602_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/path.2522","volume":"218","author":"LHJ Looijenga","year":"2009","unstructured":"Looijenga, L. H. J. Human testicular (non)seminomatous germ cell tumours: The clinical implications of recent pathobiological insights. J. Pathol. 218, 146\u2013162 (2009).","journal-title":"J. Pathol."},{"key":"20602_CR29","doi-asserted-by":"publisher","first-page":"S91","DOI":"10.21037\/tau.2019.09.08","volume":"9","author":"M Azizi","year":"2020","unstructured":"Azizi, M. et al. Therapeutic strategies for uncommon testis cancer histologies: Teratoma with malignant transformation and malignant testicular sex cord stromal tumors. Transl. Androl. Urol. 9, S91\u2013S103 (2020).","journal-title":"Transl. Androl. Urol."},{"key":"20602_CR30","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/path.2806","volume":"223","author":"TA Farazi","year":"2011","unstructured":"Farazi, T. A., Spitzer, J. I., Morozov, P. & Tuschl, T. miRNAs in human cancer. J. Pathol. 223, 102\u2013115 (2011).","journal-title":"J. Pathol."},{"key":"20602_CR31","doi-asserted-by":"crossref","unstructured":"De Martino, M., Chieffi, P. & Esposito, F. miRNAs and biomarkers in testicular germ cell tumors: An Update. Int. J. Mol. Sci. 22, (2021).","DOI":"10.3390\/ijms22031380"},{"key":"20602_CR32","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1373\/clinchem.2014.221341","volume":"61","author":"KW Witwer","year":"2015","unstructured":"Witwer, K. W. Circulating microRNA biomarker studies: Pitfalls and potential solutions. Clin. Chem. 61, 56\u201363 (2015).","journal-title":"Clin. Chem."},{"key":"20602_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1309\/AJCPOE11KEYZCJHT","volume":"135","author":"MJ Murray","year":"2011","unstructured":"Murray, M. J. et al. Identification of microRNAs from the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am. J. Clin. Pathol. 135, 119\u2013125 (2011).","journal-title":"Am. J. Clin. Pathol."},{"key":"20602_CR34","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.eururo.2012.02.037","volume":"61","author":"G Belge","year":"2012","unstructured":"Belge, G., Dieckmann, K.-P., Spiekermann, M., Balks, T. & Bullerdiek, J. Serum levels of microRNAs miR-371-3: A novel class of serum biomarkers for testicular germ cell tumors?. Eur. Urol. 61, 1068\u20131069 (2012).","journal-title":"Eur. Urol."},{"key":"20602_CR35","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/JU.0000000000001337","volume":"205","author":"RR Badia","year":"2021","unstructured":"Badia, R. R. et al. Real-world application of pre-orchiectomy miR-371a-3p test in testicular germ cell tumor management. J. Urol. 205, 137\u2013144 (2021).","journal-title":"J. Urol."},{"key":"20602_CR36","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.eururo.2019.10.005","volume":"77","author":"JT Lafin","year":"2020","unstructured":"Lafin, J. T. et al. Serum MicroRNA-371a-3p levels predict viable germ cell tumor in chemotherapy-na\u00efve patients undergoing retroperitoneal lymph node dissection. Eur. Urol. 77, 290\u2013292 (2020).","journal-title":"Eur. Urol."},{"key":"20602_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.eururo.2019.06.010","volume":"76","author":"N Singla","year":"2019","unstructured":"Singla, N., Lafin, J. T. & Bagrodia, A. MicroRNAs: Turning the tide in testicular cancer. Eur. Urol. 76, 541\u2013542 (2019).","journal-title":"Eur. Urol."},{"key":"20602_CR38","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s11255-024-04284-2","volume":"57","author":"S Zujuan","year":"2025","unstructured":"Zujuan, S., Xin, D., Yang, H. & Guifu, Z. Potential next generation markers of testicular germ cell tumors: miRNA-371a-3p. Int. Urol. Nephrol. 57, 691\u2013700 (2025).","journal-title":"Int. Urol. Nephrol."},{"key":"20602_CR39","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1038\/s41416-021-01643-z","volume":"126","author":"CD Fankhauser","year":"2022","unstructured":"Fankhauser, C. D. et al. Detection of recurrences using serum miR-371a-3p during active surveillance in men with stage I testicular germ cell tumours. Br. J. Cancer 126, 1140\u20131144 (2022).","journal-title":"Br. J. Cancer"},{"key":"20602_CR40","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.juro.2018.02.068","volume":"200","author":"R Le\u00e3o","year":"2018","unstructured":"Le\u00e3o, R. et al. Serum miRNA predicts viable disease after chemotherapy in patients with testicular nonseminoma germ cell tumor. J. Urol. 200, 126\u2013135 (2018).","journal-title":"J. Urol."},{"key":"20602_CR41","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1530\/ERC-11-0271","volume":"19","author":"GW Novotny","year":"2012","unstructured":"Novotny, G. W. et al. MicroRNA expression profiling of carcinoma in situ cells of the testis. Endocr. Relat. Cancer 19, 365\u2013379 (2012).","journal-title":"Endocr. Relat. Cancer"},{"key":"20602_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s12943-015-0411-4","volume":"14","author":"TB Rounge","year":"2015","unstructured":"Rounge, T. B. et al. Profiling of the small RNA populations in human testicular germ cell tumors shows global loss of piRNAs. Mol. Cancer 14, 153 (2015).","journal-title":"Mol. Cancer"},{"key":"20602_CR43","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.2230","volume":"213","author":"AJM Gillis","year":"2007","unstructured":"Gillis, A. J. M. et al. High-throughput microRNAome analysis in human germ cell tumours. J. Pathol. 213, 319\u2013328 (2007).","journal-title":"J. Pathol."},{"key":"20602_CR44","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s00428-012-1325-9","volume":"461","author":"Z Bing","year":"2012","unstructured":"Bing, Z. et al. MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue. Virchows Arch. 461, 663\u2013668 (2012).","journal-title":"Virchows Arch."},{"key":"20602_CR45","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/j.clgc.2018.10.007","volume":"17","author":"R Le\u00e3o","year":"2019","unstructured":"Le\u00e3o, R., Ahmad, A. E. & Hamilton, R. J. Testicular cancer biomarkers: A role for precision medicine in testicular cancer. Clin. Genitourin. Cancer 17, e176\u2013e183 (2019).","journal-title":"Clin. Genitourin. Cancer"},{"key":"20602_CR46","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1080\/14737159.2019.1685383","volume":"20","author":"M Chovanec","year":"2020","unstructured":"Chovanec, M., Kalavska, K., Mego, M. & Cheng, L. Liquid biopsy in germ cell tumors: Biology and clinical management. Expert. Rev. Mol. Diagn. 20, 187\u2013194 (2020).","journal-title":"Expert. Rev. Mol. Diagn."},{"key":"20602_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.21873\/invivo.11757","volume":"34","author":"G Belge","year":"2020","unstructured":"Belge, G., Grobelny, F., Matthies, C., Radtke, A. & Dieckmann, K.-P. Serum level of microRNA-375-3p is not a reliable biomarker of teratoma. In Vivo 34, 163\u2013168 (2020).","journal-title":"In Vivo"},{"key":"20602_CR48","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.ucl.2022.09.002","volume":"50","author":"J Egan","year":"2023","unstructured":"Egan, J. & Salari, K. Biomarkers in testicular cancer: Classic tumor markers and beyond. Urol. Clin. North Am. 50, 133\u2013143 (2023).","journal-title":"Urol. Clin. North Am."},{"key":"20602_CR49","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.euo.2021.02.002","volume":"5","author":"A Gerdtsson","year":"2022","unstructured":"Gerdtsson, A. et al. Unilateral or bilateral retroperitoneal lymph node dissection in nonseminoma patients with postchemotherapy residual tumour? Results from RETROP, a population-based mapping study by the Swedish Norwegian testicular cancer group. Eur. Urol. Oncol. 5, 235\u2013243 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"20602_CR50","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/annonc\/mdt425","volume":"25","author":"P Ravi","year":"2014","unstructured":"Ravi, P., Gray, K. P., O\u2019Donnell, E. K. & Sweeney, C. J. A meta-analysis of patient outcomes with subcentimeter disease after chemotherapy for metastatic non-seminomatous germ cell tumor. Ann. Oncol. 25, 331\u2013338 (2014).","journal-title":"Ann. Oncol."},{"key":"20602_CR51","doi-asserted-by":"crossref","unstructured":"Lobo, J. et al. Identification and validation model for informative liquid biopsy-based microRNA Biomarkers: Insights from germ cell tumor in vitro, in vivo and patient-derived data. Cells 8, (2019).","DOI":"10.3390\/cells8121637"},{"key":"20602_CR52","doi-asserted-by":"crossref","unstructured":"Yodkhunnatham, N., Pandit, K., Puri, D., Yuen, K. L. & Bagrodia, A. MicroRNAs in testicular germ cell tumors: The teratoma challenge. Int. J. Mol. Sci. 25, (2024).","DOI":"10.3390\/ijms25042156"},{"key":"20602_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.humpath.2018.07.016","volume":"82","author":"J Lobo","year":"2018","unstructured":"Lobo, J. et al. Testicular germ cell tumors: Revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists. Hum. Pathol. 82, 113\u2013124 (2018).","journal-title":"Hum. Pathol."},{"key":"20602_CR54","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1200\/JCO.2013.53.5831","volume":"32","author":"G Daugaard","year":"2014","unstructured":"Daugaard, G. et al. Surveillance for stage I nonseminoma testicular cancer: Outcomes and long-term follow-up in a population-based cohort. J. Clin. Oncol. 32, 3817\u20133823 (2014).","journal-title":"J. Clin. Oncol."},{"key":"20602_CR55","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.annonc.2022.01.002","volume":"33","author":"J Oldenburg","year":"2022","unstructured":"Oldenburg, J. et al. Testicular seminoma and non-seminoma: ESMO-EURACAN clinical practice guideline for diagnosis, treatment and follow-up. Ann. Oncol. 33, 362\u2013375 (2022).","journal-title":"Ann. Oncol."},{"key":"20602_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.4161\/epi.25799","volume":"9","author":"B-F Chen","year":"2014","unstructured":"Chen, B.-F., Gu, S., Suen, Y.-K., Li, L. & Chan, W.-Y. microRNA-199a-3p, DNMT3A, and aberrant DNA methylation in testicular cancer. Epigenetics 9, 119\u2013128 (2014).","journal-title":"Epigenetics"},{"key":"20602_CR57","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/sj.bjc.6605505","volume":"102","author":"HH Cheung","year":"2010","unstructured":"Cheung, H. H. et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer. Br. J. Cancer 102, 419\u2013427 (2010).","journal-title":"Br. J. Cancer"},{"key":"20602_CR58","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MOU.0000000000001017","volume":"32","author":"FC Martin","year":"2022","unstructured":"Martin, F. C. et al. Genetics of testicular cancer: A review. Curr. Opin. Urol. 32, 481\u2013487 (2022).","journal-title":"Curr. Opin. Urol."},{"key":"20602_CR59","doi-asserted-by":"crossref","unstructured":"Singh, R., Fazal, Z., Freemantle, S. J. & Spinella, M. J. Between a rock and a hard place: An epigenetic-centric view of testicular germ cell tumors. Cancers (Basel) 13, (2021).","DOI":"10.3390\/cancers13071506"},{"key":"20602_CR60","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/path.2725","volume":"221","author":"H Wermann","year":"2010","unstructured":"Wermann, H. et al. Global DNA methylation in fetal human germ cells and germ cell tumours: Association with differentiation and cisplatin resistance. J. Pathol. 221, 433\u2013442 (2010).","journal-title":"J. Pathol."},{"key":"20602_CR61","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.cell.2006.02.037","volume":"124","author":"PM Voorhoeve","year":"2006","unstructured":"Voorhoeve, P. M. et al. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Cell 124, 1169\u20131181 (2006).","journal-title":"Cell"},{"key":"20602_CR62","doi-asserted-by":"publisher","first-page":"154611","DOI":"10.1016\/j.prp.2023.154611","volume":"248","author":"AS Doghish","year":"2023","unstructured":"Doghish, A. S. et al. The potential role of miRNAs in the pathogenesis of testicular germ cell tumors - A focus on signaling pathways interplay. Pathol. Res. Pract. 248, 154611 (2023).","journal-title":"Pathol. Res. Pract."},{"key":"20602_CR63","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.eururo.2024.10.023","volume":"87","author":"V Tateo","year":"2025","unstructured":"Tateo, V. et al. Epidemiology and risk factors for testicular cancer: A systematic review. Eur. Urol. 87, 427\u2013441 (2025).","journal-title":"Eur. Urol."},{"key":"20602_CR64","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/andr.12388","volume":"5","author":"M Levy","year":"2017","unstructured":"Levy, M. et al. Mendelian randomisation analysis provides no evidence for a relationship between adult height and testicular cancer risk. Andrology 5, 914\u2013922 (2017).","journal-title":"Andrology"},{"key":"20602_CR65","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/ng.3879","volume":"49","author":"Z Wang","year":"2017","unstructured":"Wang, Z. et al. Meta-analysis of five genome-wide association studies identifies multiple new loci associated with testicular germ cell tumor. Nat. Genet. 49, 1141\u20131147 (2017).","journal-title":"Nat. Genet."},{"key":"20602_CR66","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.eururo.2021.06.006","volume":"80","author":"R Le\u00e3o","year":"2021","unstructured":"Le\u00e3o, R. et al. Circulating MicroRNAs, the next-generation serum biomarkers in testicular germ cell tumours: A systematic review. Eur. Urol. 80, 456\u2013466 (2021).","journal-title":"Eur. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20602-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20602-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T21:02:37Z","timestamp":1761426157000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-20602-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["20602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-20602-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,10,21]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"36715"}}